Colchicine for Community-Treated Patients with COVID-19 (COLCORONA): A Phase III, Randomised, Double-Blinded, Adaptive, Placebo-Controlled, Multicenter Trial

Colchicine is an oral anti-inflammatory medication beneficial in gout, pericarditis, and coronary disease. Scientists investigated the effect of colchicine on the composite of COVID-19-related death or hospital admission.